Patents Assigned to MedTrain Technologies, LLC
  • Patent number: 9018009
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: April 28, 2015
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Patent number: 8993325
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: March 31, 2015
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Patent number: 8877500
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: November 4, 2014
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Publication number: 20140242696
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Application
    Filed: January 29, 2014
    Publication date: August 28, 2014
    Applicant: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Publication number: 20140242697
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Application
    Filed: January 29, 2014
    Publication date: August 28, 2014
    Applicant: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Publication number: 20140220688
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Application
    Filed: January 29, 2014
    Publication date: August 7, 2014
    Applicant: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Patent number: 8663988
    Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: March 4, 2014
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
  • Patent number: 8288511
    Abstract: The present provides nuclear localization signaling (NLS) sequences derived from titin, comprised of amino acids 181-220: SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR and fragments thereof, such as amino acids 193-208: VQGEEEVP AKKTKTIV; amino acids 199-208: VPAKKTKTIV; and amino acids 200-206: PAKKTKT. The NLS sequences can be linked to agents, such as peptides, proteins or nucleotides, for transporting the agents into the nucleus of cells, and the NLS-agent complex can be further linked to antibodies or ligands for specific binding to cells. Also provided is a method for constructing cDNAs comprising combining a NLS sequence with a nucleic acid sequence for a target protein for expression and entry of the target protein into the nucleus of cells, which then can perform specific functions therein.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: October 16, 2012
    Assignee: Medtrain Technologies, LLC
    Inventors: Albert J. Banes, Jie Qi
  • Patent number: 7738682
    Abstract: Disclosed is a tissue engineered construct analytical imaging system (10) for use with culture wells (12) having tissue engineered constructs therein, which are positionable in an incubator apparatus (16) or other enclosed environment. The system (10) includes an imaging device (18) in operational communication with the enclosed environment for obtaining data reflective of a well area of interest in the culture well (12), without the removal of the culture well (12) from the enclosed environment. A computer controller (20) can receive data from the imaging device (18), analyze the data and determine desired parameters within the well area of interest and/or output data reflective of the results of the analysis. A computer-implemented method of obtaining and analyzing images of tissue engineered constructs is also disclosed.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: June 15, 2010
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Melissa Marie Maloney
  • Publication number: 20100041128
    Abstract: The present invention provides a cell culture device for applying shear stress and strain on single cells. The device includes at least one channel, at least one cell culture chamber having at least one single-cell attachment surface, a flexible membrane, at least one vacuum channel, and an inlet and an outlet. The inventive single-cell culture assembly fluid flow for applying fluid induced stress and/or substrate induced stress to cultured cells.
    Type: Application
    Filed: January 8, 2009
    Publication date: February 18, 2010
    Applicant: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Jian Wang, Michelle E. Wall
  • Publication number: 20090275136
    Abstract: The present provides nuclear localization signaling (NLS) sequences derived from titin, comprised of amino acids 181-220: SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR and fragments thereof, such as amino acids 193-208: VQGEEEVP AKKTKTIV; amino acids 199-208: VPAKKTKTIV; and amino acids 200-206: PAKKTKT. The NLS sequences can be linked to agents, such as peptides, proteins or nucleotides, for transporting the agents into the nucleus of cells, and the NLS-agent complex can be further linked to antibodies or ligands for specific binding to cells. Also provided is a method for constructing cDNAs comprising combining a NLS sequence with a nucleic acid sequence for a target protein for expression and entry of the target protein into the nucleus of cells, which then can perform specific functions therein.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 5, 2009
    Applicant: Medtrain Technologies, LLC
    Inventors: Albert J. Banes, Jie Qi
  • Patent number: 7531624
    Abstract: The present provides nuclear localization signaling (NLS) sequences derived from titin, comprised of amino acids 181-220: SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR and fragments thereof, such as amino acids 193-208: VQGEEEVP AKKTKTIV; amino acids 199-208: VPAKKTKTIV; and amino acids 200-206: PAKKTKT. The NLS sequences can be linked to agents, such as peptides, proteins or nucleotides, for transporting the agents into the nucleus of cells, and the NLS-agent complex can be further linked to antibodies or ligands for specific binding to cells. Also provided is a method for constructing cDNAs comprising combining a NLS sequence with a nucleic acid sequence for a target protein for expression and entry of the target protein into the nucleus of cells, which then can perform specific functions therein.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: May 12, 2009
    Assignee: Medtrain Technologies, LLC
    Inventors: Albert J. Banes, Jie Qi
  • Patent number: 6998265
    Abstract: An apparatus (10) to grow cell cultures includes an anchor (14) potted to a flexible membrane (12) and an anchor stem (16) to which cells attach. A jig (18) having a trough (46) and at least one passage (52) is positioned adjacent the flexable membrane (12). A method for growing and mechanically conditioning three-dimensional cell constructs begins by drawing the flexible membrane (12) and the anchor stem (14) into the trough (46) by means (20) for flexing the flexible membrane (12) (step 114). Cells are supplied (step 116) and allowed to attach to the anchor stem (16) (step 118). The flexible membrane (12) is released from within the trough (46) (step 120), resulting in a three-dimensional structure (34) of cells attached to the anchor stem (16). The cells grow into the three-dimensional construct (step 130). The structure (34) and/or the construct can be subjected to a regimen of strain for mechanical conditioning of the cells (step 132).
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: February 14, 2006
    Assignee: MedTrain Technologies, LLC
    Inventor: Albert J. Banes
  • Patent number: D694904
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: December 3, 2013
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Colin Frazier, Christopher Wimmer
  • Patent number: D880721
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: April 7, 2020
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Colin Patrick Frazier, Christopher James Wimmer
  • Patent number: D918413
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: May 4, 2021
    Assignee: MedTrain Technologies, LLC
    Inventors: Albert J. Banes, Colin Patrick Frazier, Christopher James Wimmer